FOXA
53
-2
VIX
57
7
HRB
51
2
DFS
47
5
TJX
50
2
SBUX
45
-2
ETR
66
-2
KO
65
-3
PLD
45
8
PG
63
-5
AFL
59
-3
EXR
48
2
MCD
57
-2
EXPE
67
-2
EBAY
45
-4
NFLX
68
-2
OKE
70
-4
AVGO
27
-8
WM
77
-3
IBM
55
-2
FOXA
53
-2
VIX
57
7
HRB
51
2
DFS
47
5
TJX
50
2
SBUX
45
-2
ETR
66
-2
KO
65
-3
PLD
45
8
PG
63
-5
AFL
59
-3
EXR
48
2
MCD
57
-2
EXPE
67
-2
EBAY
45
-4
NFLX
68
-2
OKE
70
-4
AVGO
27
-8
WM
77
-3
IBM
55
-2
Financhill
Back

ArcelorMittal SA 10K Form

Buy
60

MT
ArcelorMittal SA

Last Price:
$32.83
Seasonality Move:
7.79%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MT News And Ratings

See the #1 stock for the next 7 days that we like better than MT

MT Financial Statistics

Sales & Book Value

Annual Sales: $62.4B
Cash Flow: $1.3B
Price / Cash Flow: 57.56
Annual Sales: $64.05
Price / Book: 0.51

Profitability

EPS (TTM): 1.65000
Net Income (TTM): $1.3B
Gross Margin: $5.8B
Return on Equity: 2.46%
Return on Assets: 1.46%

ArcelorMittal SA Earnings Forecast

Key ArcelorMittal SA Financial Ratios

  • The Gross Profit Margin over the past 28 years for MT is 9.27%.
  • The Selling, General & Administrative Expenses for MT have been equal to 3.97% of Gross Profit Margin.
  • The Research & Development expenses have been 0.00% of Revenue.
  • The Interest Expense is 38.09% of Operating Income.
  • The Net Earning history of MT is 2.14% of Total Revenues.
  • Per Share Earnings over the last 28 years have been positive in 15 years.

ArcelorMittal SA Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Metals & Mining
Sector: Materials
Current Symbol: MT
CUSIP: 03938L
Website: arcelormittal.com

Debt

Debt-to-Equity Ratio: 0.21
Current Ratio: 1.35
Quick Ratio: 0.55

Price-to-Earnings

Trailing P/E Ratio: 19.24
Forward P/E Ratio: 6.14

MT Technical Analysis vs Fundamental Analysis

Buy
60
ArcelorMittal SA (MT) is a Buy

Is ArcelorMittal SA a Buy or a Sell?

  • ArcelorMittal SA stock is rated a Buy
    The current ArcelorMittal SA [MT] share price is $32.52. The Score for MT is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.